SYMATESE Announces Submission to U.S. FDA for its Pre-market approval Application for its HA dermal fillers

SFB: from 19 to 21 June, come and meet us on stand B1!

SYMATESE DEVICE at “The Pharma Days” in Geneva

Lacrifill®: a new dry eye treatment by Nordic Pharma

SYMATESE celebrates 10 years with NEVELIA®

SYMATESE launches SYMATESE LAB

1st class III product under MDR CE marking

EVOLUS talks about its partnership with SYMATESE at IMCAS

IMCAS 2024: what a success for SYMATESE!

SYMATESE takes over GROUPE SEBBIN

SYMATESE: discover our strong presence at IMCAS 2024

SYMATESE DEVICE is at PHARMAPACK 2024